专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2006083536A1 AMINOALKOXYPHENYL INDOLONE DERIVATIVES 审中-公开
标题翻译：氨基羟基苯酚吲哚酮衍生物
公开(公告)号：WO2006083536A1
公开(公告)日：2006-08-10
申请号：PCT/US2006/001522
申请日：2006-01-18
申请人： H. LUNDBECK A/S , KONKEL, Michael , PACKIARAJAN, Mathivanan , CHEN, Heidi , TOPIWALA, Upendra , JIMENEZ, Hermogenes , TALISMAN, Jamie
发明人： KONKEL, Michael , PACKIARAJAN, Mathivanan , CHEN, Heidi , TOPIWALA, Upendra , JIMENEZ, Hermogenes , TALISMAN, Jamie
IPC分类号： C07D209/40
CPC分类号： C07D209/34 , C07D403/12 , C07D405/12
摘要： This invention is directed to aminoalkoxyphenyl indolone derivatives, which are ligands at the GAL3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the subject invention.
摘要翻译：本发明涉及作为GAL3受体的配体的氨基烷氧基苯基吲哚酮衍生物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括给予受试者一定量的本发明化合物。

2. 发明申请

WO2006083538A1 AMINOALKYLPHENYL INDOLONE DERIVATIVES 审中-公开
标题翻译：氨基苯酚吲哚酮衍生物
公开(公告)号：WO2006083538A1
公开(公告)日：2006-08-10
申请号：PCT/US2006/001527
申请日：2006-01-18
申请人： H. LUNDBECK A/S , KONKEL, Michael , PACKIARAJAN, Mathivanan , CHEN, Heidi
发明人： KONKEL, Michael , PACKIARAJAN, Mathivanan , CHEN, Heidi
IPC分类号： A61K31/41 , C07D209/40
CPC分类号： C07D209/40 , C07D403/10
摘要： This invention is directed to aminoalkylphenyl indolone derivatives, which are ligands at the GAL 3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/ or anxiety which comprises administering to the subject an amount of a compound of the subject invention.
摘要翻译：本发明涉及作为GAL 3受体的配体的氨基烷基苯基吲哚酮衍生物。本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。本发明还提供了制备药物组合物的方法，其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。本发明还提供了治疗患有抑郁症和/或焦虑症的受试者的方法，其包括给予受试者一定量的本发明化合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式